{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:21:01Z","timestamp":1778782861135,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.phrs.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T18:57:36Z","timestamp":1483815456000},"page":"274-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences"],"prefix":"10.1016","volume":"117","author":[{"given":"Marco","family":"Proietti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Mazurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.01.004_bib0005","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.01.004_bib0010","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","article-title":"Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes","volume":"37","author":"EUGenMed Cardiovascular Clinical Study Group","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.01.004_bib0015","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/IJWH.S45925","article-title":"Epidemiology, diagnosis, and management of atrial fibrillation in women","volume":"7","author":"Poli","year":"2015","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.phrs.2017.01.004_bib0020","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.01.004_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1160\/TH09-02-0106","article-title":"Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients","volume":"101","author":"Lane","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0030","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.phrs.2017.01.004_bib0035","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2017.01.004_bib0040","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.01.004_bib0045","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.01.004_bib0050","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.01.004_bib0055","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.01.004_bib0060","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.01.004_bib0065","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1055\/s-0035-1564042","article-title":"Gender difference in efficacy and safety of nonvitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation or venous thromboembolism: a systematic review and a meta-analysis of the literature","volume":"41","author":"Dentali","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0070","doi-asserted-by":"publisher","DOI":"10.2174\/1570161113666150216152054","article-title":"Old and new oral anticoagulants In management of atrial fibrillation: a double-Edged sword for women","author":"Basili","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0075","article-title":"A focused review of gender differences in antithrombotic therapy","author":"Salzano","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2017.01.004_bib0080","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/eurheartj\/ehl103","article-title":"Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials","volume":"27","author":"Gomberg-Maitland","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.01.004_bib0085","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/STROKEAHA.114.005746","article-title":"Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study","volume":"45","author":"Lip","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2017.01.004_bib0090","first-page":"3268","article-title":"Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial","volume":"36","author":"Vinereanu","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.01.004_bib0095","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCOUTCOMES.114.001398","article-title":"Sex differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation","volume":"8","author":"Avgil Tsadok","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes."},{"key":"10.1016\/j.phrs.2017.01.004_bib0100","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0002-8703(03)00325-9","article-title":"Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)","volume":"146","author":"Halperin","year":"2003","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.01.004_bib0105","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.amjcard.2015.12.040","article-title":"Gender differences of thromboembolic events in atrial fibrillation","volume":"117","author":"Cheng","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0110","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.01.004_bib0115","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.amjcard.2004.06.023","article-title":"Copenhagen City Heart Study, Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study)","volume":"94","author":"Friberg","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0120","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jacc.2006.10.047","article-title":"Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"49","author":"Dagres","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0125","doi-asserted-by":"publisher","first-page":"e3522","DOI":"10.1136\/bmj.e3522","article-title":"Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study","volume":"344","author":"Friberg","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.01.004_bib0130","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0135","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1160\/TH14-06-0545","article-title":"Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study","volume":"112","author":"Overvad","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0140","doi-asserted-by":"publisher","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.01.004_bib0145","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-Year results from the ORBIT-AF registry","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0150","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1160\/TH13-04-0347","article-title":"Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms","volume":"111","author":"Cove","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0155","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1161\/STROKEAHA.114.006668","article-title":"Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial","volume":"45","author":"Apostolakis","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2017.01.004_bib0160","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM)","volume":"110","author":"Sullivan","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0165","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.phrs.2017.01.004_bib0170","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1160\/TH13-07-0556","article-title":"Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation","volume":"110","author":"Gallego","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.01.004_bib0175","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijcard.2016.01.169","article-title":"Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: the AFFIRM trial","volume":"207","author":"Proietti","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.01.004_bib0180","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.05.060","article-title":"Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation","author":"Proietti","year":"2015","journal-title":"Am. J. Cardiol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816309550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T04:18:52Z","timestamp":1568693932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816309550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"alternative-id":["S1043661816309550"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.01.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}